Tugas Analisis Laporan Keuangan sub sektor farmasi dan Riset Kesehatan - PT Kimia Farma Tbk

Summary

This presentation provides an in-depth financial analysis of PT Kimia Farma Tbk, one of Indonesia's oldest pharmaceutical companies. It covers key aspects of the company's financial performance from 2018 to 2022, including balance sheet comparisons, income statement analysis, liquidity, leverage, and profitability ratios. The presentation also includes trend and common-size analyses, DuPont analysis, and a break-even analysis. The analysis shows how Kimia Farma has adapted to challenges, particularly during the COVID-19 pandemic, highlighting its ability to maintain financial stability despite external pressures.

Takeaways

• 😀 PT Kimia Farma Tbk is one of the oldest pharmaceutical companies in Asia, founded in 1817, originally established by the Dutch colonial government and later nationalized in 1957.
• 😀 The company operates in the pharmaceutical and healthcare industry, producing prescription drugs, over-the-counter medicines, health devices, cosmetics, and herbal products.
• 😀 Kimia Farma provides healthcare services through a network of pharmacies and clinics spread across Indonesia.
• 😀 A variety of financial analysis methods were employed in evaluating PT Kimia Farma’s financial health, including balance sheet comparisons, profit-and-loss analysis, and ratio analysis.
• 😀 The liquidity ratios analyzed include Current Ratio, Cash Ratio, and Working Capital to Total Asset Ratio, helping evaluate the company’s ability to cover short-term obligations.
• 😀 Leverage ratios were calculated, such as the Debt-to-Asset and Debt-to-Equity ratios, to assess the company’s financial leverage and reliance on debt to finance operations.
• 😀 Activity ratios like Asset Turnover, Inventory Turnover, and Working Capital Turnover were used to evaluate the efficiency of asset utilization and inventory management.
• 😀 Profitability ratios such as Gross Profit Margin, Operating Income Ratio, and Return on Equity were examined to assess the company’s ability to generate profit relative to revenue and assets.
• 😀 The DuPont analysis was performed to break down Return on Equity (ROE) into key components: Net Profit Margin, Asset Turnover, and Equity Multiplier.
• 😀 The company’s performance was compared against industry peers through cross-sectional and time series analysis, highlighting PT Kimia Farma’s relative standing in the pharmaceutical sector.

Q & A

What is the main focus of the presentation?

The main focus of the presentation is the financial analysis of PT Kimia Farma Tbk, including various financial ratios, trends, and comparisons with other companies in the pharmaceutical industry.

What is PT Kimia Farma Tbk and when was it established?

PT Kimia Farma Tbk is a leading pharmaceutical company in Indonesia, established in 1817, making it one of the oldest pharmaceutical companies in Asia. Initially founded by the Dutch colonial government, it was nationalized in 1957.

What types of products does Kimia Farma produce?

Kimia Farma produces prescription drugs, over-the-counter products, health equipment, cosmetics, and herbal products. It also operates pharmacies and health clinics across Indonesia.

What are the key sections of the financial analysis in the presentation?

The key sections include comparative balance sheet analysis, income statement analysis, ratio analysis (liquidity, leverage, activity, profitability), DuPont analysis, common size analysis, trend analysis, cross-section analysis, time series analysis, cash flow and capital sources analysis, and break-even analysis.

How does the presentation define liquidity ratios, and what are some examples?

Liquidity ratios assess a company's ability to meet short-term obligations. Examples include the current ratio, quick ratio, working capital to total asset ratio, and cash ratio.

What is DuPont analysis, and how is it applied in this presentation?

DuPont analysis is used to calculate Return on Equity (ROE) by breaking it down into profit margin, asset turnover, and equity multiplier. This helps analyze the company's financial performance more comprehensively.

What is the purpose of common size analysis?

The purpose of common size analysis is to express financial statement items as percentages of a base figure, such as total assets or total equity, to facilitate easier comparison over time or with other companies.

What does trend analysis focus on in this presentation?

Trend analysis focuses on comparing financial data over time, using 2018 as the base year. It highlights changes in key metrics like total assets, liabilities, equity, and profitability across different years.

What companies are used for comparison in the cross-section analysis?

The cross-section analysis compares PT Kimia Farma's financial metrics with other pharmaceutical companies like PT Tempo Scan Pacific Tbk, PT Darya Varia Laboratoria Tbk, PT Papros Tbk, and PT Organon Pharma Indonesia Tbk.

What is the significance of the break-even analysis in this context?

The break-even analysis is used to determine the point at which the company's total revenue equals its total expenses, both fixed and variable. This helps assess when the company starts generating profits.

How did PT Kimia Farma adapt to challenges during the COVID-19 pandemic?

During the pandemic, PT Kimia Farma experienced significant changes in its financial conditions. The company adjusted its strategies to maintain stability while also seizing new opportunities in response to market changes.